We are live on ! Find out more
GSK icon

GSK
GSK

763 hedge funds and large institutions have $9.69B invested in GSK in 2017 Q4 according to their latest regulatory filings, with 135 funds opening new positions, 168 increasing their positions, 348 reducing their positions, and 109 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 135 | Existing positions closed: 109

3% more funds holding

Funds holding: 741 → 763 (+22)

7% more call options, than puts

Call options by funds: $107M | Put options by funds: $99.7M

0.46% more ownership

Funds ownership: 3.95% → 4.41% (+0.46%)

2% less capital invested

Capital invested by funds: $9.84B → $9.69B (-$148M)

10% less funds holding in top 10

Funds holding in top 10: 10 → 9 (-1)

52% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 348

Holders
763
Holders Change
+22
Holders Change %
+2.97%
% of All Funds
17.31%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.2%
New
135
Increased
168
Reduced
348
Closed
109
Calls
$107M
Puts
$99.7M
Net Calls
+$7.16M
Net Calls Change
-$43.6M

Top Buyers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
+$1.08B
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$624M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$66.9M
4
CCM
Camber Capital Management
Massachusetts
+$55.4M
5
Millennium Management
Millennium Management
New York
+$48.7M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$197M
2
Bank of America
Bank of America
North Carolina
-$125M
3
HCM
Hamlin Capital Management
New York
-$72M
4
MHI
Miller Howard Investments
New York
-$56.4M
5
Morgan Stanley
Morgan Stanley
New York
-$38.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
BONST
826
Bank of Nova Scotia Trust
Ontario, Canada
– -$256K -5,052 Closed
V
827
Veritable
Delaware
– -$254K -5,002 Closed
EHWM
828
Eads & Heald Wealth Management
Georgia
– -$254K -4,998 Closed
S
829
SignatureFD
Georgia
– -$252K -4,968 Closed
DWT
830
Dorsey & Whitney Trust
South Dakota
– -$249K -4,906 Closed
BMO
831
Beck Mack & Oliver
New York
– -$244K -4,798 Closed
VNA
832
VNBTrust National Association
Virginia
– -$242K -4,766 Closed
HVIA
833
Hudson Valley Investment Advisors
New York
– -$239K -4,706 Closed
FBT
834
First Bankers Trust
Kentucky
– -$237K -4,677 Closed
CCM
835
Coldstream Capital Management
Washington
– -$237K -4,666 Closed
CC
836
Cadinha & Co
Hawaii
– -$235K -4,638 Closed
PWLP
837
Prio Wealth Limited Partnership
Massachusetts
– -$234K -4,628 Closed
SBIA
838
Sheaff Brock Investment Advisors
Indiana
– -$233K -4,594 Closed
IC
839
Intersect Capital
California
– -$233K -4,584 Closed
NL
840
NWAM LLC
Washington
– -$231K -4,558 Closed
AB
841
AT Bancorp
Iowa
– -$231K -4,555 Closed
ECM
842
Elgethun Capital Management
South Dakota
– -$221K -4,355 Closed
DWA
843
Douglass Winthrop Advisors
New York
– -$218K -4,288 Closed
BCM
844
Birmingham Capital Management
Alabama
– -$217K -4,280 Closed
IB
845
Intrust Bank
Kansas
– -$217K -4,277 Closed
AW
846
ACG Wealth
Georgia
– -$217K -4,275 Closed
TBNY
847
Trustco Bank (New York)
New York
– -$215K -4,240 Closed
WP
848
WMS Partners
Maryland
– -$214K -4,225 Closed
RB
849
Rodgers Brothers
Pennsylvania
– -$214K -4,218 Closed
1SB
850
1ST Source Bank
Indiana
– -$213K -4,206 Closed
31 32 33
34
35

GSK Hedge Fund Activity: Q4 2017 in Review

763 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2017, worth a combined $9.69B — down 1.5% from $9.84B a quarter earlier.

Buyers outnumbered sellers: 135 funds opened new GSK positions and 109 closed out — a net gain of 26 holders — while 168 added to existing stakes and 348 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $1.08B. The largest seller was Wells Fargo, cutting an estimated $197M.

  • 763 institutional investors held GSK (GSK) as of Q4 2017, up from 741 in Q3 2017.
  • Funds reported $9.69B of GSK stock for Q4 2017, down 1.5% quarter-over-quarter.
  • 135 funds opened new GSK positions in Q4 2017 and 109 closed out, a net change of +26 holders.
  • The largest GSK buyer in Q4 2017 was Dodge & Cox, an estimated $1.08B added.
  • The largest GSK seller in Q4 2017 was Wells Fargo, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2017.